Tilray has completed a type 2 bullish shark and caught followthrough price action on Friday.
Long to the three targets. If you are seeing this late then I'd wait on a down day to enter, if it never comes then you've missed the entry and another opportunity will arise.
We are also long on SNDL with a similar but weaker setup
2024 has been very busy for NASDAQ:ACB
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free
- Aurora Partners with Script Assist to Provide Better Access to UK Medical...
Canopy Growth Corporation: Navigating Market Challenges and Strategic Goals
Canopy Growth Corporation, a prominent player in the cannabis industry, has been a focal point for investors seeking exposure to the rapidly expanding market for legal marijuana products. As one of the largest cannabis producers globally, Canopy Growth has garnered attention for its...
As of the most recent data, the S&P 500, which represents the performance of 500 of the largest companies listed on stock exchanges in the United States, is trading at an impressive level. The index has been on a bullish trend, consistently reaching new all-time highs in recent months. This upward trajectory can be attributed to a combination of factors, including...
f you find this information inspiring/helpful, please consider a boost and follow! Any questions or comments, please leave a comment! Also, check out the links in my signature to get to know me better!
MSOS News pump, so a short based off of past trends could be warrented, but watching for a nice correction and some reactions off of these levels starting at 6.44 and 5.56.
Since the IPO, Leafly has lost over 99% of its value.
Leafly's management team throws shares at retail investors on a monthly basis and feeds the short positions of hedge funds.
As long as Leafly continues to get beat up by hedge funds, prices will continue to fall.
There is steadily more selling than buying. The demand is very low.
In the long term, the stock...
Looks like it, we have another touch of the bottom of the wedge and bullish divergence on MACD. A first potential target zone is around $1.50-$1.60 and second target zone should be a double top at around $1.90-$2.0.
First off for summary:
Grow Generation is a leading retailer of hydroponic and organic gardening products in the United States. The company was founded in 2014 and is headquartered in Denver, Colorado. Grow Generation provides a wide range of products and services for indoor and outdoor gardening, including hydroponic and organic growing equipment, nutrients, and...
It's time to activate our wake-up call to get Aurora back into motion, since we expect the course to rise up North, even though it is still creeping sideways momentarily. In our alternative scenario, there is a slight probability of 33% that the course could drop below the $1.14 support line instead. In this case, it would continue to move South until it reaches...
It must be 420 somewhere, since the Jazz Pharmaceuticals stock is paving its way higher and higher to ultimately reach the orange target zone. Once the blue wave (b) is completed, the stock should drop all the way below the $125.36 support line and continue the correction until the end of the green wave within the yellow trading area. Once the course has hit the...
Just like the Ball in Times Square every New Year's Eve, the Canopy Growth stock is currently dropping it low. We expect the course to dig deeper into the blue trading area between C$3.49 and C$0.70 until it finishes the grey wave II. After completion, we're expecting the course to rise further North in the longterm. In our alternative scenario, the Canopy Growth...
Will it pull up the
AdvisorShares Psychedelics ETF?
Strength in the #Biotech sector would also be a friendly situation.
here are the top holdings:
CMPS COMPASS PATHWAYS PLC 13.12%
ATAI ATAI LIFE SCIENCES NV 9.73%
CYBN CYBIN INC 7.97%
SEEL SEELOS THERAPEUTICS INC 6.90%
ITCI INTRA-CELLULAR THERAPIES INC 6.44%
HUGE FSD PHARMA INC-CLASS B 5.82%
SAGE SAGE...
This is just a thought here - although this appears to be a never-ending downtrend, I wonder if this on-balance volume divergence signals something. This shows that buyers are willing to step in here a bit more aggressively than the previous "bottom," as shown by higher OBV despite lower prices - even though OBV has declined overall since its peak. We're also...
Playing this one. My entry at 3.37
Quick swing trade. removed all indicators for clear view of the plan.
looking at an inverse head and shoulders pattern, target is the horizontal resistance level.
Quick in n out.
As stated in the previous analysis for bigger picture please check previous for smaller period see out it is going to be played. Higher chance of Cup and handle!
I do believ the Cannabis Sector will see a rally later on in the year and this appears to be a very nice place to take an entry on this particular stock.
We are not out of the weeds yet. Get it?
stupid dad Joke
We are back down to buying prices and with inflation/fed rates priced in we've had a good month.
If we can break and hold above the downtrend line we could see a little rally to $6-$8 range.
I don't think it will last long though and we will more likely have a double bottom.
Seems like federal...
